| View |
|
DRP-3493-10
|
Multivitamins + Buclizine Hydrochloride
|
MaxGrow
|
Retinol Acetate (Vitamin A) 2,000 IU
Cholecalciferol (Vitamin D3) 200 IU
Alpha Tocopheryl Acetate (Vitamin E) 1 IU
Ascorbic Acid (Vitamin C) 60 mg
Niacinamide 18 mg
Buclizine Hydrochloride 5 mg
D-Panthenol 3 mg
Thiamine Hydrochloride (Vitamin B1) 1 mg
Riboflavin-5-Phosphate Sodium (Vitamin B2) 1 mg
Pyridoxine Hydrochloride (Vitamin B6) 1 mg
Cyanocobalamin (Vitamin B12) 1 mcg
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 October 2023
|
28 February 2026
|
| View |
|
DRP-7603-04
|
Tramadol Hydrochloride + Paracetamol
|
None
|
37.5 mg/ 325 mg
|
Film-Coated Tablet
|
Analgesic (Opioid and non-opioid combination)
|
Hizon Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 October 2023
|
04 June 2025
|
| View |
|
DRP-8996-01
|
Pemetrexed (as disodium heptahydrate)
|
Trexed
|
500 mg
|
Lyophilized Powder for Injection for I.V. Infusion
|
Antineoplastic (Folic Acid Analogue)
|
ADMAC Lifesciences
|
India
|
Renewal
|
09 November 2024
|
29 July 2030
|
| View |
|
DRP-13238-06
|
Ursodeoxycholic Acid
|
Usonav
|
250 mg
|
Capsule
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 October 2023
|
06 January 2028
|
| View |
|
DRP-14267-01
|
Losartan potassium
|
None
|
50 mg
|
Film-coated Tablet
|
Angiotensin II Receptor Blocker
|
Novagen Healthcare Private Limited
|
India
|
CLIDP Conversion
|
27 October 2023
|
30 June 2028
|
| View |
|
DRP-14269-01
|
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Fluzep
|
325 mg/25 mg/2 mg
|
Tablet
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
27 October 2023
|
28 August 2027
|
| View |
|
DRP-9415-02
|
Iohexol
|
Kinhexol
|
755mg/mL (eq. to 350mg/mL Iodine)
|
Solution for Injection (Intravascular/Intraarticular/Oral or Rectal Administration/Oral In Conjunction with Intravenous Administration/Body Cavity)
|
X-ray contrast Media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 October 2023
|
23 December 2025
|
| View |
|
HRP-146-02
|
Paracetamol
|
None
|
100 mg / mL
|
Suspension (Oral Drops) (Alcohol Free) (Tutti Frutti Flavor)
|
Analgesic / Antipyretic
|
Lumar Pharmaceutical Laboratory, Inc
|
Philippines
|
CLIDP Conversion
|
26 October 2023
|
05 May 2025
|
| View |
|
DRP-1458-14
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Vitamoon-B
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamin
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
26 October 2023
|
18 December 2025
|
| View |
|
DRP-3246-05
|
Dicycloverine (as Hydrochloride)
|
Reliefas
|
10 mg/5 mL
|
Syrup
|
Anticholinergic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
26 October 2023
|
22 September 2026
|
| View |
|
DRP-9328-01
|
Ketorolac Trometamol
|
Exalac
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Steroidal Anti-inflammatory (Acetic Acid Derivative)
|
Friends Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
26 October 2023
|
26 November 2024
|
| View |
|
DRP-9885-13
|
Ascorbic Acid + Zinc
|
Corbate-Z
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin / Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
26 October 2023
|
25 January 2026
|
| View |
|
DRP-10994-01
|
Azithromycin (as dihydrate)
|
Zithrolab
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 October 2023
|
31 December 2026
|
| View |
|
DRP-11813-03
|
Telmisartan + Amlodipine (as besilate)
|
None
|
40 mg/5 mg
|
Tablet
|
Angiotensin II antagonist / Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 October 2023
|
02 May 2027
|
| View |
|
DRP-12155-02
|
Atorvastatin (as Calcium Trihydrate)
|
Atorvex-20
|
20 mg
|
Film-coated Tablet
|
HMG-Coa Reductase Inhibitor
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 October 2023
|
22 June 2027
|
| View |
|
DRP-12592-01
|
Cefixime (as trihydrate)
|
Cefiden
|
20 mg/mL
|
Powder for Oral Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
26 October 2023
|
19 September 2027
|
| View |
|
DRP-12735-03
|
Telmisartan + Amlodipine (as besilate)
|
Telarb CCB
|
80mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
26 October 2023
|
30 September 2027
|
| View |
|
DRP-12738-04
|
Telmisartan + Amlodipine (as besilate)
|
Telarb CCB
|
40mg/5mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
26 October 2023
|
30 September 2027
|
| View |
|
DRP-13376-02
|
Telmisartan + Amlodipine (as besilate)
|
None
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 October 2023
|
08 February 2028
|
| View |
|
DRP-13379-02
|
Pregabalin + Methylcobalamin
|
Nervagest Plus
|
75mg / 750mcg
|
Capsule
|
Antiepileptic / Vitamin (Cyanocobalamin analogue)
|
Bafna Pharmaceuticals Limited
|
India
|
Renewal
|
21 October 2024
|
08 February 2030
|